Acute cholecystitis during treatment with alemtuzumab in 3 patients with RRMS

Neurology. 2016 Nov 29;87(22):2380-2381. doi: 10.1212/WNL.0000000000003379. Epub 2016 Oct 28.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alemtuzumab / adverse effects*
  • Antibodies, Monoclonal / adverse effects*
  • Cholecystitis, Acute / chemically induced*
  • Cholecystitis, Acute / diagnostic imaging
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Tomography, X-Ray Computed
  • Ultrasonography

Substances

  • Antibodies, Monoclonal
  • Alemtuzumab